Tag: single cell multiomics market

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Single Cell Multiomics Market Value Analysis: What Growth Is Expected Over The Forecast Period?

The market for single-cell multiomics has experienced remarkable expansion, projecting a rise from $4.85 billion in 2025 to $5.92 billion in 2026, driven by a robust compound annual growth rate of 22.1%. This growth trajectory, observed over the historical period, is underpinned by several key factors including significant progress in single-cell sequencing technologies, a broadening scope of cancer research projects, escalating investment in life sciences endeavors, enhanced accessibility of advanced high-throughput analytical instruments, and increased financial support for academic investigations.

Anticipated to expand significantly over the forthcoming years, the market for single-cell multiomics is projected to reach $13 billion by 2030, demonstrating a compound annual growth rate of 21.7%. This upward trajectory is fueled by several key factors, including a heightened need for precision medicine solutions, greater integration within clinical research processes, the proliferation of platforms designed to merge multiomics data, augmented investment in pharmaceutical R&D, and ongoing enhancements in analytical precision. Key developments set to shape this market during the projected period involve a greater embrace of unified multiomics platforms, a surge in demand for detailed single-cell examinations, increased utilization of artificial intelligence for data interpretation, broader implementation of techniques for multi-modal cellular profiling, and a more pronounced focus on understanding cellular diversity.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20630&type=smp

Single Cell Multiomics Market Expansion Drivers: What Is Shaping Future Growth?

The market for single-cell multiomics is poised for expansion, driven by the escalating need for precision medicine. This approach to healthcare customizes treatments and strategies based on an individual’s unique biological makeup. The surge in precision medicine is attributable to breakthroughs in genetic research, improved data processing power, and a greater appreciation for the benefits of personalized care. By offering granular information on cellular variations and molecular processes, single-cell multiomics facilitates the creation of sophisticated, individualized therapies designed around a patient’s specific cellular makeup. Illustrating this trend, the Personalized Medicine Coalition (PMC) reported that in 2023, the U.S. Food and Drug Administration (FDA) authorized 18 new personalized medicines, representing approximately 38% of all new therapeutic compounds introduced that year. Consequently, the growing emphasis on precision medicine is a key catalyst for the advancement of the single-cell multiomics sector.

Single Cell Multiomics Market Segment Landscape: Which Areas Lead Market Development?

The single cell multiomics market covered in this report is segmented –

1) By Type: Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics

2) By Technique: Single Cell Isolation And Dispensing, Single Cell Analysis

3) By Application: Oncology, Cell Biology, Neurology, Immunology, Stem Cell Research

4) By End User: Academic Institutes, Contract Research Organizations, Pharmaceutical And Biotech Companies

Subsegments:

1) By Single Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single Cell DNA Amplification Techniques, Genomic Analysis Platforms

2) By Single Cell Proteomics: Mass Spectrometry-Based Techniques, Protein Microarrays, Enzyme-Linked Immunosorbent Assays (ELISA), Single Cell Protein Analysis Platforms

3) By Single Cell Transcriptomics: Single Cell RNA Sequencing (scRNA-seq), RNA Amplification Techniques, Microfluidics-Based Transcriptomics, Transcriptome Analysis Tools

4) By Single Cell Metabolomics: Mass Spectrometry For Metabolite Analysis, Nuclear Magnetic Resonance (NMR) Techniques, Liquid Chromatography For Metabolomics, Metabolite Profiling Tools

Single Cell Multiomics Market Strategic Trends: What Is Defining The Next Phase Of Growth?

In the realm of single-cell multiomics, leading entities are actively engaged in creating advanced single-cell multiomics assays aimed at refining the precision and detail of cellular investigations. These sophisticated assays empower scientists to gain deeper insights into intricate biological mechanisms, pinpoint elusive cell types, and personalize therapeutic strategies by consolidating extensive molecular information derived from individual cells. As a concrete illustration, Mission Bio, a biotechnology firm situated in the United States, unveiled its Tapestri Single-cell Multiple Myeloma Multiomics Solution in June 2024. This groundbreaking offering facilitates an exhaustive examination of multiple myeloma at the individual cell level. Consequently, this solution equips researchers focusing on translational studies and those involved in drug development with the capability to thoroughly map the molecular and cellular intricacies throughout the progression of myeloid disorders, investigate mechanisms of treatment resistance, and pinpoint the fundamental factors driving disease evolution from its nascent phases, including conditions like monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Single Cell Multiomics Market Industry Leaders And Market Competition

Major companies operating in the single cell multiomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Illumina Inc., BioRad Laboratories Inc., QIAGEN N.V., BioTechne Corporation, Miltenyi Biotec BV & Co KG, BGI Genomics Co Ltd, 10x Genomics Inc., Molecular Devices LLC, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., Takara Bio Inc., Synthego Corporation, Mission Bio Inc., DeepCell Inc., RareCyte Inc., Parse Biosciences Inc., Dolomite Bio Ltd, Stilla Technologies SAS, NanoCellect Biomedical Inc., Epicypher Inc., Scipio Biosciences SAS

Access The Complete Single Cell Multiomics Market Report:

https://www.thebusinessresearchcompany.com/report/single-cell-multiomics-global-market-report

Single Cell Multiomics Market Geographic Distribution And Regional Opportunities

North Americawas the largest region in the single cell multiomics market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the single cell multiomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Growth In Market Size Of The Single Cell Multiomics Market During 2026–2030?

The single cell multiomics market has experienced substantial expansion in recent times. It is projected to increase from $4.85 billion in 2025 to $5.92 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 22.1%. This historical growth was largely propelled by progress in single-cell sequencing technologies, the broadening of cancer research initiatives, increasing investments in life sciences research, enhanced access to high-throughput analysis tools, and expanding academic research funding.

The single cell multiomics market size is projected to undergo significant expansion over the next few years. It is expected to achieve a value of $13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 21.7%. This growth during the forecast period can be attributed to the escalating demand for precision medicine applications, wider integration into clinical research workflows, the proliferation of multiomics data integration platforms, increasing investments in pharmaceutical research, and sustained advancements in analytical sensitivity. Significant trends for this period involve the rising adoption of integrated multiomics platforms, a heightened requirement for high-resolution single-cell analysis, the increasing utilization of AI-driven data interpretation tools, the development of multi-modal cellular profiling techniques, and a stronger emphasis on insights into cellular heterogeneity.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20630&type=smp

Which Significant Factors Are Encouraging Growth In The Single Cell Multiomics Market?

The growing need for precision medicine is anticipated to drive the expansion of the single cell multiomics market in the future. Precision medicine denotes a medical methodology that customizes treatments and healthcare plans based on each patient’s unique attributes. This rise in precision medicine stems from progress in genomic research, improved data analysis functionalities, and a greater appreciation for the benefits of personalized healthcare. Single-cell multiomics offers comprehensive insights into how cells differ and their molecular workings, which facilitates the creation of highly customized treatments designed for specific patients’ distinct cellular makeups. For example, in May 2025, the U.S.-based professional organization, Personalized Medicine Coalition (PMC), reported that in 2023, the U.S. Food and Drug Administration (FDA) sanctioned 18 new personalized medicines, accounting for approximately 38% of all recently approved therapeutic molecular entities. Consequently, the rising requirement for precision medicine is fueling the expansion of the single cell multiomics market.

What Segment Categories Are Evaluated In The Single Cell Multiomics Market Study?

The single cell multiomics market covered in this report is segmented –

1) By Type: Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics

2) By Technique: Single Cell Isolation And Dispensing, Single Cell Analysis

3) By Application: Oncology, Cell Biology, Neurology, Immunology, Stem Cell Research

4) By End User: Academic Institutes, Contract Research Organizations, Pharmaceutical And Biotech Companies

Subsegments:

1) By Single Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single Cell DNA Amplification Techniques, Genomic Analysis Platforms

2) By Single Cell Proteomics: Mass Spectrometry-Based Techniques, Protein Microarrays, Enzyme-Linked Immunosorbent Assays (ELISA), Single Cell Protein Analysis Platforms

3) By Single Cell Transcriptomics: Single Cell RNA Sequencing (scRNA-seq), RNA Amplification Techniques, Microfluidics-Based Transcriptomics, Transcriptome Analysis Tools

4) By Single Cell Metabolomics: Mass Spectrometry For Metabolite Analysis, Nuclear Magnetic Resonance (NMR) Techniques, Liquid Chromatography For Metabolomics, Metabolite Profiling Tools

What Trends Are Driving Changes In The Single Cell Multiomics Market?

Major companies within the silver wound dressing market are concentrating on developing advanced products, such as antimicrobial wound dressings, to address the increasing demand for more effective and sustainable wound care solutions. Antimicrobial wound dressings are sophisticated wound care products infused with antimicrobial agents to prevent or minimize infections. For instance, in November 2024, Imbed Biosciences, a US-based biotechnology company, introduced Microlyte Ag/Lidocaine, an antimicrobial wound dressing that integrates lidocaine, which obtained Food and Drug Administration (FDA) 510(k) clearance for managing painful skin wounds. This innovative dressing utilizes Imbed’s patented synthetic matrix to deliver ionic and metallic silver alongside lidocaine, providing antimicrobial protection and local anesthetic effects by releasing 40 mg of lidocaine hydrochloride USP per 100 cm² of the wound area. It is indicated for various partial- and full-thickness wounds, including venous stasis ulcers, pressure sores, ischemic ulcers, burns, surgical wounds, and abrasions, potentially reducing infection risk and pain while lowering reliance on systemic antibiotics and opioids.

Who Are The Key Market Participants In The Single Cell Multiomics Market?

Major companies operating in the single cell multiomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Illumina Inc., BioRad Laboratories Inc., QIAGEN N.V., BioTechne Corporation, Miltenyi Biotec BV & Co KG, BGI Genomics Co Ltd, 10x Genomics Inc., Molecular Devices LLC, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., Takara Bio Inc., Synthego Corporation, Mission Bio Inc., DeepCell Inc., RareCyte Inc., Parse Biosciences Inc., Dolomite Bio Ltd, Stilla Technologies SAS, NanoCellect Biomedical Inc., Epicypher Inc., Scipio Biosciences SAS

Access The Complete Single Cell Multiomics Market Report:

https://www.thebusinessresearchcompany.com/report/single-cell-multiomics-global-market-report

Which Geographic Region Represents The Largest Single Cell Multiomics Market Share?

North America was the largest region in the single cell multiomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single cell multiomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Single Cell Multiomics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20630&type=smp

Browse Through More Reports Similar to the Global Single Cell Multiomics Market 2026, By The Business Research Company

Flow Cytometry In Oncology And Immunology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Stem Cell Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

Cellular Telephone Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Single Cell Multiomics Market Be By 2030 Compared To Its 2026 Market Size?

The single cell multiomics market size has experienced rapid growth in recent years. Projections indicate it will expand from $4.85 billion in 2025 to $5.92 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.1%. This historical expansion can be primarily ascribed to breakthroughs in single-cell sequencing technologies, a surge in cancer research initiatives, increased funding within life sciences research, enhanced access to high-throughput analysis tools, and an uptick in academic research funding.

The single cell multiomics market is projected to experience rapid expansion in the coming years. This market is anticipated to reach a valuation of $13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 21.7%. The projected expansion during this period stems from several factors, including the escalating need for precision medicine applications, greater integration into clinical research processes, the proliferation of multiomics data integration platforms, increased funding for pharmaceutical research, and ongoing advancements in analytical sensitivity. Key trends anticipated within the forecast timeframe involve the wider acceptance of integrated multiomics platforms, a heightened requirement for high-resolution single-cell analysis, the increasing deployment of AI-powered data interpretation tools, the development of multi-modal cellular profiling methodologies, and a stronger emphasis on understanding cellular heterogeneity.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20630&type=smp

Which Primary Drivers Are Impacting The Single Cell Multiomics Market Growth?

The expanding requirement for precision medicine is expected to drive the growth of the single cell multiomics market in the future. Precision medicine refers to a medical approach that customizes treatment and healthcare strategies based on the individual characteristics of each patient. The rise in precision medicine is fueled by advancements in genomic research, enhanced data analysis capabilities, and a heightened understanding of personalized healthcare advantages. Single-cell multiomics provides detailed insights into cellular heterogeneity and molecular mechanisms, enabling the development of highly personalized treatments tailored to individual patients’ unique cellular profiles. For instance, in May 2025, according to the Personalized Medicine Coalition (PMC), in 2023, the U.S. Food and Drug Administration (FDA) approved 18 new personalized medicines, representing about 38% of all newly approved therapeutic molecular entities. Therefore, the increasing demand for precision medicine is propelling the growth of the single cell multiomics market.

What Are The Different Segment Types In The Single Cell Multiomics Market Segment Breakdown?

The single cell multiomics market covered in this report is segmented –

1) By Type: Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics

2) By Technique: Single Cell Isolation And Dispensing, Single Cell Analysis

3) By Application: Oncology, Cell Biology, Neurology, Immunology, Stem Cell Research

4) By End User: Academic Institutes, Contract Research Organizations, Pharmaceutical And Biotech Companies

Subsegments:

1) By Single Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single Cell DNA Amplification Techniques, Genomic Analysis Platforms

2) By Single Cell Proteomics: Mass Spectrometry-Based Techniques, Protein Microarrays, Enzyme-Linked Immunosorbent Assays (ELISA), Single Cell Protein Analysis Platforms

3) By Single Cell Transcriptomics: Single Cell RNA Sequencing (scRNA-seq), RNA Amplification Techniques, Microfluidics-Based Transcriptomics, Transcriptome Analysis Tools

4) By Single Cell Metabolomics: Mass Spectrometry For Metabolite Analysis, Nuclear Magnetic Resonance (NMR) Techniques, Liquid Chromatography For Metabolomics, Metabolite Profiling Tools

Which Trends Are Shaping Growth In The Single Cell Multiomics Market?

Leading companies within the single cell multiomics market are actively developing single-cell multiomics tests to elevate the precision and resolution of cellular analysis. These single-cell multiomics tests empower researchers to gain a clearer understanding of complex biological processes, identify rare cell populations, and customize precision medicine approaches by integrating thorough molecular data from individual cells. For example, in June 2024, Mission Bio, a US-based biotechnology company, introduced its Tapestri Single-cell Multiple Myeloma Multiomics Solution. This solution facilitates comprehensive profiling of multiple myeloma at single-cell resolution, allowing translational researchers and drug developers to fully dissect the molecular and cellular landscape during myeloid progression, understand therapy resistance, and identify drivers of disease evolution from early stages such as monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).

Who Are The Well-Known Companies In The Single Cell Multiomics Market?

Major companies operating in the single cell multiomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Illumina Inc., BioRad Laboratories Inc., QIAGEN N.V., BioTechne Corporation, Miltenyi Biotec BV & Co KG, BGI Genomics Co Ltd, 10x Genomics Inc., Molecular Devices LLC, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., Takara Bio Inc., Synthego Corporation, Mission Bio Inc., DeepCell Inc., RareCyte Inc., Parse Biosciences Inc., Dolomite Bio Ltd, Stilla Technologies SAS, NanoCellect Biomedical Inc., Epicypher Inc., Scipio Biosciences SAS

Get The Full Single Cell Multiomics Market Report:

https://www.thebusinessresearchcompany.com/report/single-cell-multiomics-global-market-report

Which Region Holds The Highest Market Share In The Single Cell Multiomics Market?

North America was the largest region in the single cell multiomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single cell multiomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Single Cell Multiomics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/single-cell-multiomics-global-market-report

Browse Through More Reports Similar to the Global Single Cell Multiomics Market 2026, By The Business Research Company

Flow Cytometry In Oncology And Immunology Market Report 2026

https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Stem Cell Market Report

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

Cellular Telephone Market Report

https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Single Cell Multiomics Market Over The Period 2026–2030?

The size of the single cell multiomics market has experienced rapid expansion over recent years. This market is projected to expand from $4.85 billion in 2025 to $5.92 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.1%. The historical growth of this market can be linked to several factors, including improvements in single-cell sequencing technologies, an increase in cancer research efforts, greater investment in life sciences research, enhanced access to high-throughput analysis instruments, and increased financial support for academic research.

The single cell multiomics market size is projected for rapid expansion over the next few years. It is anticipated to reach $13 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 21.7%. This growth during the forecast period is primarily driven by rising demand for precision medicine applications, increasing adoption in clinical research workflows, the expansion of multiomics data integration platforms, growing investments in pharmaceutical research, and continuous improvements in analytical sensitivity. Key trends in the forecast period encompass the increasing adoption of integrated multiomics platforms, a rising demand for high-resolution single-cell analysis, the growing use of AI-driven data interpretation tools, the expansion of multi-modal cellular profiling techniques, and an enhanced focus on insights into cellular heterogeneity.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20630&type=smp

Which Economic Or Industry Drivers Are Impacting The Single Cell Multiomics Market?

The escalating demand for precision medicine is projected to stimulate the growth of the single cell multiomics market moving forward. Precision medicine refers to a medical methodology that customizes treatment and healthcare approaches based on the unique characteristics of individual patients. This increase in precision medicine is spurred by advancements in genomic research, enhanced data analysis capabilities, and a clearer understanding of the advantages of personalized healthcare. Single-cell multiomics delivers detailed insights into cellular heterogeneity and molecular mechanisms, enabling the formulation of highly personalized treatments tailored to the distinct cellular profiles of individual patients. For instance, in May 2025, the U.S. Food and Drug Administration (FDA) approved 18 new personalized medicines in 2023, representing about 38% of all newly approved therapeutic molecular entities, according to the U.S.-based professional organization, the Personalized Medicine Coalition (PMC). Therefore, the escalating demand for precision medicine is driving the expansion of the single cell multiomics market.

How Is The Single Cell Multiomics Market Divided Into Its Major Segments?

The single cell multiomics market covered in this report is segmented –

1) By Type: Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics

2) By Technique: Single Cell Isolation And Dispensing, Single Cell Analysis

3) By Application: Oncology, Cell Biology, Neurology, Immunology, Stem Cell Research

4) By End User: Academic Institutes, Contract Research Organizations, Pharmaceutical And Biotech Companies

Subsegments:

1) By Single Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single Cell DNA Amplification Techniques, Genomic Analysis Platforms

2) By Single Cell Proteomics: Mass Spectrometry-Based Techniques, Protein Microarrays, Enzyme-Linked Immunosorbent Assays (ELISA), Single Cell Protein Analysis Platforms

3) By Single Cell Transcriptomics: Single Cell RNA Sequencing (scRNA-seq), RNA Amplification Techniques, Microfluidics-Based Transcriptomics, Transcriptome Analysis Tools

4) By Single Cell Metabolomics: Mass Spectrometry For Metabolite Analysis, Nuclear Magnetic Resonance (NMR) Techniques, Liquid Chromatography For Metabolomics, Metabolite Profiling Tools

What Trends Are Advancing Progress In The Single Cell Multiomics Market?

Leading companies in the single cell multiomics market are actively developing single-cell multiomics tests to improve the accuracy and resolution of cellular analysis. These tests empower researchers to gain a deeper understanding of complex biological processes, identify scarce cell populations, and customize precision medicine strategies by consolidating extensive molecular data from individual cells. For example, in June 2024, Mission Bio, a US-based biotechnology company, introduced its Tapestri Single-cell Multiple Myeloma Multiomics Solution. This solution facilitates thorough profiling of multiple myeloma at a single-cell level, allowing translational researchers and drug developers to meticulously examine the molecular and cellular landscape during myeloid progression, comprehend therapy resistance, and pinpoint the catalysts of disease evolution from early stages like monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).

Who Are The Prominent Organizations Shaping The Single Cell Multiomics Market?

Major companies operating in the single cell multiomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Illumina Inc., BioRad Laboratories Inc., QIAGEN N.V., BioTechne Corporation, Miltenyi Biotec BV & Co KG, BGI Genomics Co Ltd, 10x Genomics Inc., Molecular Devices LLC, NanoString Technologies Inc., Standard BioTools Inc., Akoya Biosciences Inc., Takara Bio Inc., Synthego Corporation, Mission Bio Inc., DeepCell Inc., RareCyte Inc., Parse Biosciences Inc., Dolomite Bio Ltd, Stilla Technologies SAS, NanoCellect Biomedical Inc., Epicypher Inc., Scipio Biosciences SAS

Read the full single cell multiomics market report here:

https://www.thebusinessresearchcompany.com/report/single-cell-multiomics-global-market-report

What Are The Top-Performing Regions Within The Single Cell Multiomics Market?

North America was the largest region in the single cell multiomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single cell multiomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Single Cell Multiomics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20630&type=smp

Browse Through More Reports Similar to the Global Single Cell Multiomics Market 2026, By The Business Research Company

Flow Cytometry In Oncology And Immunology Global Market Report

https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Stem Cell Global Market Report

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

Cellular Telephone Global Market Report

https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model